Visit Us on the Web: http://www.themarketechgroup.com/?utm_source=SlideShare&utm_medium=Social+Media&utm_campaign=How+To+Identify+Opportunities
About Us:
With offices in North America and Europe, The MarkeTech Group provides a unique combination of extensive marketing research methodology expertise, deep medical technology domain knowledge and value-added strategic marketing consulting to medical technology companies who seek high quality marketing research studies and professional marketing strategy consulting.
The MarkeTech Group's team of marketing research and strategy experts take pride in integrating their leading voice of customer (VOC) research expertise and strategic consulting into their clients' marketing and R&D departments to help successfully launch and maintain profitable products in healthcare.
The MarkeTech Group, LLC
502 Mace Blvd, Suite 15
Davis, CA 95618
Tele: (+1) 530-792-8400
Fax: (+1) 530-792-8447
The MarkeTech Group, SARL
3, Rue Emile Péhant
44 000 Nantes
Tele: +33 (0)2 72 01 00 80
Fax: +33 (0)2 40 48 29 40
Contact Us: http://www.themarketechgroup.com/index.php?page=Contact_TMTG&utm_source=SlideShare&utm_medium=Social+Media&utm_campaign=How+To+Identify+Opportunities
Five Steps to Find your 'Beyond the Pill' Strategyexecutiveinsight
A short window of opportunity exists for pharmaceutical companies to establish indispensable beyond the pill services, which may even help them 'own' particular disease areas.
Beyond-the-pill: how to move from selling pills to value-added solutionsexecutiveinsight
New shores: The shift from selling pills to developing value-added services has only just begun!
Biopharma companies are discovering that compelling and aligned services underpinned by a core strategy are providing them with distinctive competitive advantages.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Global regenerative medicines market (technology, application and geography) ...Allied Market Research
Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process.
Five Steps to Find your 'Beyond the Pill' Strategyexecutiveinsight
A short window of opportunity exists for pharmaceutical companies to establish indispensable beyond the pill services, which may even help them 'own' particular disease areas.
Beyond-the-pill: how to move from selling pills to value-added solutionsexecutiveinsight
New shores: The shift from selling pills to developing value-added services has only just begun!
Biopharma companies are discovering that compelling and aligned services underpinned by a core strategy are providing them with distinctive competitive advantages.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Global regenerative medicines market (technology, application and geography) ...Allied Market Research
Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process.
This presents the resource-based theory of competitive advantage as a framework for describing, understanding, and predicting the adoption and dissemination pharmacy service innovations into routine practice. The theory argues that sustainability of any business innovation (e.g., pharmacy service) is based upon (1) the internal resources of the firm offering it, (2) the firm’s capabilities in using those resources, (3) the competitive advantage to the firm of its resources and capabilities, (4) the attractiveness of the market in which it competes, and (5) the innovation’s contribution to financial performance of the firm.
SMi Group presents the 23rd annual industry leading summit on Pharmaceutical Pricing & Market Access, 11 – 12 Oct 2017, London, UK.
Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical and payer landscape. Join us this autumn for insight into how manufactures plan to limit further price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); stakeholder collaboration; meaningful patient engagement opportunities; and discuss what can be done for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.
Highlights will include an exclusive opening keynote from the FDA and interactive training on Real World Evidence (RWE). Featured Speakers include: Lundbeck, FDA, Shire, Sobi, Teva, Grifols, Allergan, Sanofi and more!
This presentation will discuss the business issues surrounding technology and capital equipment, and the role of specialized patient care units and non-acute patient care facilities as part of the healthcare business environment.
Successful market / customer access is a primary objective in healthcare marketing. This presentation provides the insight to successfully position, price and promote your pharmaceutical, medical device or clinical service in leading healthcare market segments.
This presentation is from www.healthcaremedicalpharmaceuticaldirectory.com, no subscription is required. Please visit us to see more presentations about the latest marketing trends in the healthcare industry.
John Baresky Healthcare Marketing Leader, Pharmaceutical Marketing, Digital Marketing Strategy, Content Marketing Strategy, Market Access Strategy, Healthcare RPA Software Marketing Strategy
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
2016. Dosage Form Optimization: Technology to Advance the Patient-Centric Dru...Valentyn Mohylyuk
A supplement to American Pharmaceutical Review
September / October 2016
Dosage Form Optimization: Technology to Advance the Patient-Centric Drug-Development Process
Catalent Development
This presentation gives an overview of what is acceptable in Canadian pharmaceutical advertising to healthcare professionals. It was used to introduce new Account Executives to working with the PAAB code (Fall 2006). It does not reflect more recent changes to the code.
This Atrium Health study and pilot program revealed healthcare savings potential resulting from a tailored approach to medication adherence and specialty drug programs.
The MarkeTech Group Scientific Method Webinar by Robert Enzerink and James Garvin
How Much Are Clinical Customers Willing To Pay? -- Using Voice-of-the-Customer To Get Your Key Questions Answered
Trying to determine what features and benefits you should go to market with or which of those features your customers truly value the most and are willing to pay a premium for,...can be one tough nut to crack.
A common challenge in the medical field is to move beyond the internal filters and biases created when your input comes primarily through your sales force and KOL channels.
KOLs tend to be early adopters and technology geeks; engineering teams are convinced that a more technically advanced product will sell itself; sales will push for lower prices so they can compete; and regulatory bodies like CMS keep tightening reimbursement pressures... Executives need credible information to guide decisions.
The MarkeTech Group
502 Mace Blvd.
Davis, CA 95618
www.themarketechgroup.com
This presents the resource-based theory of competitive advantage as a framework for describing, understanding, and predicting the adoption and dissemination pharmacy service innovations into routine practice. The theory argues that sustainability of any business innovation (e.g., pharmacy service) is based upon (1) the internal resources of the firm offering it, (2) the firm’s capabilities in using those resources, (3) the competitive advantage to the firm of its resources and capabilities, (4) the attractiveness of the market in which it competes, and (5) the innovation’s contribution to financial performance of the firm.
SMi Group presents the 23rd annual industry leading summit on Pharmaceutical Pricing & Market Access, 11 – 12 Oct 2017, London, UK.
Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical and payer landscape. Join us this autumn for insight into how manufactures plan to limit further price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); stakeholder collaboration; meaningful patient engagement opportunities; and discuss what can be done for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.
Highlights will include an exclusive opening keynote from the FDA and interactive training on Real World Evidence (RWE). Featured Speakers include: Lundbeck, FDA, Shire, Sobi, Teva, Grifols, Allergan, Sanofi and more!
This presentation will discuss the business issues surrounding technology and capital equipment, and the role of specialized patient care units and non-acute patient care facilities as part of the healthcare business environment.
Successful market / customer access is a primary objective in healthcare marketing. This presentation provides the insight to successfully position, price and promote your pharmaceutical, medical device or clinical service in leading healthcare market segments.
This presentation is from www.healthcaremedicalpharmaceuticaldirectory.com, no subscription is required. Please visit us to see more presentations about the latest marketing trends in the healthcare industry.
John Baresky Healthcare Marketing Leader, Pharmaceutical Marketing, Digital Marketing Strategy, Content Marketing Strategy, Market Access Strategy, Healthcare RPA Software Marketing Strategy
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
2016. Dosage Form Optimization: Technology to Advance the Patient-Centric Dru...Valentyn Mohylyuk
A supplement to American Pharmaceutical Review
September / October 2016
Dosage Form Optimization: Technology to Advance the Patient-Centric Drug-Development Process
Catalent Development
This presentation gives an overview of what is acceptable in Canadian pharmaceutical advertising to healthcare professionals. It was used to introduce new Account Executives to working with the PAAB code (Fall 2006). It does not reflect more recent changes to the code.
This Atrium Health study and pilot program revealed healthcare savings potential resulting from a tailored approach to medication adherence and specialty drug programs.
The MarkeTech Group Scientific Method Webinar by Robert Enzerink and James Garvin
How Much Are Clinical Customers Willing To Pay? -- Using Voice-of-the-Customer To Get Your Key Questions Answered
Trying to determine what features and benefits you should go to market with or which of those features your customers truly value the most and are willing to pay a premium for,...can be one tough nut to crack.
A common challenge in the medical field is to move beyond the internal filters and biases created when your input comes primarily through your sales force and KOL channels.
KOLs tend to be early adopters and technology geeks; engineering teams are convinced that a more technically advanced product will sell itself; sales will push for lower prices so they can compete; and regulatory bodies like CMS keep tightening reimbursement pressures... Executives need credible information to guide decisions.
The MarkeTech Group
502 Mace Blvd.
Davis, CA 95618
www.themarketechgroup.com
The MarkeTech Group - Near Term Trends and Impacts on Radiology WebinarThe MarkeTech Group
We've assembled a panel of some of the leading Imaging Directors in the U.S. to hear directly from them their sentiments and perspectives on what Radiology departments (and imaging vendors) can expect in the near future as the dynamics in healthcare and Radiology rapidly shift.
This roundtable is a perfect opportunity for you to hear the "industry outlook" direct from the "voice of the customers."
We'll be asking Imaging Administrators to share their in-depth perspectives on:
• Expected changes in reimbursement
• Key changes in revenue drivers
• Impacts of new costs
• Near-term purchasing and investment plans
• Growth in imaging modalities and procedures
• ...AND what imaging vendors should be doing to gain their business
We think this should make for a great discussion and hope you do to.
Webinar Presentation can be found here: http://youtu.be/DdPDUjqoWLQ
Moderators:
Christian Renaudin and Mark Davis
The MarkeTech Group
502 Mace Blvd.
Davis, CA 95618
www.themarketechgroup.com
Panelists:
Stan Casteel
Imaging Director
Hamilton Medical Center
Georgia
Joe Mikoni
Director of Imaging
Boulder Community Hospital
Colorado
Ray Wilburn
Director of Radiology, Radiation Oncology, and Pain Management Services
St. Elizabeth's Medical Center
Massachusetts
Todd Stanley
Director of Radiology
Clarian Health System/Indiana University Health System
Indiana
Cette présentation de The MarkeTech Group a pour but d’introduire le marché de l’imagerie médicale en présentant les grands chiffres et les acteurs qui font ce marché puis donner le regard de l’évolution des modalités du point de vue du « marché » :
1/ Définition de l’imagerie médicale
2/ Marché de l’imagerie médicale par zone géographique
3/ Marché de l’imagerie médicale par modalité
4/ Les acteurs de l’imagerie médicale
5/ L’échographie
5/ RX/CT
6/ IRM
7/ Nucléaire
The MarkeTech Group
www.themarketechgroup.com
USA
The MarkeTech Group, LLC
502 Mace Blvd, Suite 15
Davis, CA 95618
Tele: (+1) 530-792-8400
Fax: (+1) 530-792-8447
France
The MarkeTech Group, SARL
3, Rue Emile Péhant
44 000 Nantes
Tele: +33 (0)2 72 01 00 80
Fax: +33 (0)2 40 48 29 40
Moving beyond the market segment A study of the homogenised (mis)representati...Chanel Whitcher
Moving beyond the market segment
A study of the homogenised (mis)representation of the South African family in advertising
Chanel Whitcher, 2016
KANTAR – Visio (Graphic Designer)
SAMRA 2016
Eight Proven Content Creation & Marketing Strategies with Case StudiesGold and Silver Online
This presentation shows key ways to create content easily and systematically, even if you don't consider yourself a writer, using eight content creation & marketing strategies. These were proven using a city-based blog, which is now a full fledged publication. In this session, you'll learn how one hyper local event website grew from one contributor to 25 and from zero traffic to 23,000 visitors a month, and is now syndicated by sites like Pegasus News. This is not a Social Media 101 class.
Here are some other specifics you'll learn:
- The Four Pillars of Online Marketing
- Five Goals to Have with Every Post
- Eight Tools for Benchmarking, Monitoring & Measuring Success
- Six Ways to Blog with More Authority & Credibility
We'll dig deeper in the second half of this session and get into the specifics of how to find others who will create content and market it for you, small tweaks you can make for SEO, and get into some case studies that show the results of these strategies.
More specifically you'll learn:
- Six Maximum SEO Power Positions for Your Keyword Targets
- How to Actively Recruit & Pitch Guest Bloggers
- Five things to consider when creating backlinks
- Three case studies of traffic attraction using these eight strategies
Strategic Marketing and Industrial Markets Case Study of Taiwanese Manufactur...Javier Moreno Mons.
A Case study of Taiwanese Manufacturers in their initiative to position themselves in South American Markets. It has been proposed an alternative methodology to get relevant data from industrial companies in order to understand in detail their international marketing strategy.
The comparative marketing strategies of case constructions withswastik das
the marketing strategies of case constructions. It is to know about the competition in the construction equipment that prevails in Odisha market. The target segmentation for these kinds of products are quite low due to its high cost involvement.
Comprising of various Steps, the fundamentals of advertising can be broken down to 8 steps. Followed by an intense customer & competitor analysis, the STP strategies are set which becomes the foundation of the Advertising Campaign.
"Differentiating the generics in emerging markets"Ferudun Kandemir
How are generic products perceived in emerging markets?
What are the key points in order to create a good product strategy?
What is customer oriented contextual segmentation?
How do you examine current dynamics to create preferable generics in emerging markets?
The purpose and importance of marketing research.
Steps in marketing research process
Making Marketing Research-based Decisions
and Some examples of reports and the marketing decisions they can support
C&EN BrandLab - Branding Perception in the Chemical SciencesC&EN Media Group
This webinar explores new brand research conducted by C&EN BrandLab, designed to uncover the dynamics between brand perception and decision making of key purchasers in the chemical and life sciences industry. This research identified key drivers of both purchase and recommendation of products, providing ideas for how marketers can develop campaigns that resonate with consumers to inspire purchase, recommendation and advocacy.
We provide a glimpse into how brands fared in the eyes of consumers based on their investment in branding to better understand why a commitment to consistency is necessary to succeed. Learn more about C&EN BrandLab at cenbrandlab.org.
Suzanne Hendery Branding Case Study for Renown Health.pptxSuzanne Hendery
In this case study, Suzanne Hendery of Renown Health and Cristal Herrera of Renown Health identify the steps for a successful branding strategy and customer engagement.
Crossroads: U.S. Medical Device Regulation vs. Innovation
The U.S. medical device industry is at a regulatory and potentially economic crossroad as the FDA continues to refine its 510(k) regulatory submission requirements and guidelines. Medical device manufacturers have been urging the FDA and Congress to expedite new product review processes to spur innovation and bring new medical technologies to market faster. However, supporters of stricter FDA regulations claim that a faster regulatory review process causes unsafe devices to enter the market.
As a result of numerous exchanges between both sides of the issue, CDRH (FDA) recently issued multiple updates to its initiatives for the 510(k) approval process. To shed light on key changes, we obtained the support of the office of Dr. Jeffrey Shuren MD JD, Director of CDRH and Dr. John Smith MD JD, of Hogan Lovells, a prominent international law firm with a medical regulatory specialty, on their interpretations of the 510(k) regulatory guidelines and the impact these guidelines will have on medical device manufacturers.
Listen to the Dr. John Smith podcast interview here:
http://youtu.be/iHVpwwXi7dY
The MarkeTech Group
502 Mace Blvd.
Davis, CA 95618
http://www.themarketechgroup.com
01062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
03062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
हम आग्रह करते हैं कि जो भी सत्ता में आए, वह संविधान का पालन करे, उसकी रक्षा करे और उसे बनाए रखे।" प्रस्ताव में कुल तीन प्रमुख हस्तक्षेप और उनके तंत्र भी प्रस्तुत किए गए। पहला हस्तक्षेप स्वतंत्र मीडिया को प्रोत्साहित करके, वास्तविकता पर आधारित काउंटर नैरेटिव का निर्माण करके और सत्तारूढ़ सरकार द्वारा नियोजित मनोवैज्ञानिक हेरफेर की रणनीति का मुकाबला करके लोगों द्वारा निर्धारित कथा को बनाए रखना और उस पर कार्यकरना था।
In a May 9, 2024 paper, Juri Opitz from the University of Zurich, along with Shira Wein and Nathan Schneider form Georgetown University, discussed the importance of linguistic expertise in natural language processing (NLP) in an era dominated by large language models (LLMs).
The authors explained that while machine translation (MT) previously relied heavily on linguists, the landscape has shifted. “Linguistics is no longer front and center in the way we build NLP systems,” they said. With the emergence of LLMs, which can generate fluent text without the need for specialized modules to handle grammar or semantic coherence, the need for linguistic expertise in NLP is being questioned.
31052024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
‘वोटर्स विल मस्ट प्रीवेल’ (मतदाताओं को जीतना होगा) अभियान द्वारा जारी हेल्पलाइन नंबर, 4 जून को सुबह 7 बजे से दोपहर 12 बजे तक मतगणना प्रक्रिया में कहीं भी किसी भी तरह के उल्लंघन की रिपोर्ट करने के लिए खुला रहेगा।
role of women and girls in various terror groupssadiakorobi2
Women have three distinct types of involvement: direct involvement in terrorist acts; enabling of others to commit such acts; and facilitating the disengagement of others from violent or extremist groups.
How To Identify Opportunities & Grow Market Share in a Specific Hospital Segment
1. HOW TO IDENTIFY OPPORTUNITIES
CASE STUDY
METHODOLOGIES USED:
1. Qualitative Interviews
& GROW MARKET SHARE in a
SPECIFIC HOSPITAL SEGMENT
2. The following case study and data is from a
actual CLIENT project, however the data has
been de-identified to avoid sharing any sensitive
client or confidential information and is intended
for general information only.
5. Research Objectives
CENTRAL RESEARCH QUESTION:
How can we successfully sell our diagnostic imaging product into a specific
hospital market and what is the typical KAP (Knowledge/Attitude/Practice) in
these segments?
6. Research Objectives
CENTRAL RESEARCH QUESTION:
How can we successfully sell our diagnostic imaging product into a specific
hospital market and what is the typical KAP (Knowledge/Attitude/Practice) in
these segments?
1. Define customers’ attitudes in the specific
hospital segment that can be used to support
key marketing decisions
7. Research Objectives
CENTRAL RESEARCH QUESTION:
How can we successfully sell our diagnostic imaging product into a specific
hospital market and what is the typical KAP (Knowledge/Attitude/Practice) in
these segments?
2. Confirm the sales process and the key players involved in
the purchasing process
1. Define customers’ attitudes in the specific
hospital segment that can be used to support
key marketing decisions
8. Research Objectives
CENTRAL RESEARCH QUESTION:
How can we successfully sell our diagnostic imaging product into a specific
hospital market and what is the typical KAP (Knowledge/Attitude/Practice) in
these segments?
3. Identify whether we need to do more to establish brand
awareness
2. Confirm the sales process and the key players involved in
the purchasing process
1. Define customers’ attitudes in the specific
hospital segment that can be used to support
key marketing decisions
9. Research Objectives
CENTRAL RESEARCH QUESTION:
How can we successfully sell our diagnostic imaging product into a specific
hospital market and what is the typical KAP (Knowledge/Attitude/Practice) in
these segments?
3. Identify whether we need to do more to establish brand
awareness
2. Confirm the sales process and the key players involved in
the purchasing process
1. Define customers’ attitudes in the specific
hospital segment that can be used to support
key marketing decisions
4. Formulate “best practice” approach to optimize the sales
call using input and evidence for training
10.
11. …and to provide the Client a comprehensive, unbiased view
of the current KAP (Knowledge/Attitude/Practice) in the
hospital market.
12. 30 IN-DEPTH INTERVIEWS
10 Radiologists
10 Imaging Administrators
10 C-Level Executives
GOALS
PHASE Qualitative Analysis
Identify most important
purchasing drivers and pain
points
Assess brand awareness
Identify opportunities to
grow market share
1
2
3
13. In-Depth Interviews Key Findings 1
Based on the interviews, we found
that Radiologists are the most
influential in this type of product
selection, but consensus has to be
achieved by a purchasing committee.
GOALS
Identify most important
purchasing drivers and pain
points
1
15. In-Depth Interviews Key Findings 1
Variable
?
Respondents INDICATED the TOP 4 competing brands are better than
the CLIENT at fulfilling the 6 primary purchasing factors.
Brand A
Brand B
Brand C
Brand D
CLIENT
16. In-Depth Interviews Key Findings 1
The interviews also
DETERMINED new imaging
equipment investments are
typically driven by increases in:
17. In-Depth Interviews Key Findings 1
PATIENT VOLUME,
The interviews also
DETERMINED new imaging
equipment investments are
typically driven by increases in:
18. In-Depth Interviews Key Findings 1
PATIENT VOLUME,
AGE OF EQUIPMENT,
The interviews also
DETERMINED new imaging
equipment investments are
typically driven by increases in:
19. In-Depth Interviews Key Findings 1
PATIENT VOLUME,
….and purchase upgrades by
local competitive hospitals.
AGE OF EQUIPMENT,
The interviews also
DETERMINED new imaging
equipment investments are
typically driven by increases in:
20. In-Depth Interviews Key Findings 2
GOALS
Assess brand awareness2
The CLIENT’s imaging products have nearly
NO AWARENESS while BRANDS A, B and C are
all seen as TOP-TIER.
3. BRAND C
Well known,
but lags behind
Brand A & B
5. CLIENT
Very Low
Awareness
21. In-Depth Interviews Key Findings 2
Respondents’ perceptions of
the CLIENT’s imaging product
were mostly negative…
“They have made
huge strides, but I
have never seriously
considered them.”
22. In-Depth Interviews Key Findings 2
“It's a gamble to
commit to them
– They are 2nd
Tier.”
Respondents’ perceptions of
the CLIENT’s imaging product
were mostly negative…
23. In-Depth Interviews Key Findings 2
“I do not consider them to be in
the market, no track record. Not
Top-Tier.
Respondents’ perceptions of
the CLIENT’s imaging product
were mostly negative…
24. In-Depth Interviews Key Findings 2
“They have no
presence in the
area.”
Respondents’ perceptions of
the CLIENT’s imaging product
were mostly negative…
25. In-Depth Interviews Key Findings 2
Respondents’ perceptions of
the CLIENT’s imaging product
were mostly negative…
“Do not
know them.”
26. In-Depth Interviews Key Findings 3
GOALS
Identify opportunities to grow
market share
3
Not a single respondent considered the
CLIENT’S PRODUCT for their most recent
purchase due to…
27. In-Depth Interviews Key Findings 3
…however, we FOUND that brand loyalty for this product is
generally weak, providing the CLIENT an OPPORTUNITY to take
market share from Brands A, B, C and D…
28. In-Depth Interviews Key Findings 3
…IF they can INCREASE product awareness and stake claim to a unique and
favorable position in the market to differentiate from the more reputable
technology leaders.
Best in class service
Technology Innovator
Reputable
?
?
?
BRAND ABRAND B
BRAND D
BRAND C
CLIENT
30. FINDINGS and RECOMMENDATIONS
Objectives Key Findings / Recommendations
Define customers’ attitudes in
the specific hospital segment
that can be used to support
key marketing decisions
6 PURCHASING DRIVERS
Client learned the 6 key factors that
drive product selection and how it
ranked in those factors relative to the
competition
1.
31. FINDINGS and RECOMMENDATIONS
Objectives Key Findings / Recommendations
Define customers’ attitudes in
the specific hospital segment
that can be used to support
key marketing decisions
6 PURCHASING DRIVERS
Client learned the 6 key factors that
drive product selection and how it
ranked in those factors relative to the
competition
Confirm the sales process and
the key players involved in the
purchasing process
TARGET RADIOLOGISTS
Radiologists are the key targets the
Client needs to educate and make
aware of its product
1.
2.
32. FINDINGS and RECOMMENDATIONS
Objectives Key Findings / Recommendations
Define customers’ attitudes in
the specific hospital segment
that can be used to support
key marketing decisions
6 PURCHASING DRIVERS
Client learned the 6 key factors that
drive product selection and how it
ranked in those factors relative to the
competition
Confirm the sales process and
the key players involved in the
purchasing process
TARGET RADIOLOGISTS
Radiologists are the key targets the
Client needs to educate and make
aware of its product
Identify whether we need to
do more to establish brand
awareness
INCREASE AWARENESS
The Client was surprised to learn of its
very low brand awareness and poor
perceptions in the market, but was
optimistic based on fact brand loyalty
is weak for this product category
1.
2.
3.
33. FINDINGS and RECOMMENDATIONS
Objectives Key Findings / Recommendations
Define customers’ attitudes in
the specific hospital segment
that can be used to support
key marketing decisions
6 PURCHASING DRIVERS
Client learned the 6 key factors that
drive product selection and how it
ranked in those factors relative to the
competition
Confirm the sales process and
the key players involved in the
purchasing process
TARGET RADIOLOGISTS
Radiologists are the key targets the
Client needs to educate and make
aware of its product
Identify whether we need to
do more to establish brand
awareness
INCREASE AWARENESS
The Client was surprised to learn of its
very low brand awareness and poor
perceptions in the market, but was
optimistic based on fact brand loyalty
is weak for this product category
Formulate “Best Practice”
approach to optimize the
sales call using input and
evidence for training
IMPROVE SALES PROCESS
Provided specific tactical
recommendations to improve sales
engagement with clinical and
business stakeholders based on
feedback from the interviews
1.
2.
3.
4.
34. USA
502 Mace Blvd, Suite 15
Davis, CA 95618
PH: + 1 530-792-8400
FX: + 1 530-792-8447
http://www.themarketechgroup.com/
Europe / France
3 rue Emile Péhant
44000 Nantes
PH: +33 (0)2 72 01 00 80
FX: +33 (0)2 40 48 29 40